Walgreens Board Ignored Insulin Pen Price Scheme, Suit Says (1)

A Walgreens Boots Alliance Inc. shareholder sued its board in Delaware, claiming it exposed the pharmacy giant to hundreds of millions in legal liability and lost goodwill by looking the other way for years while it “systematically” overcharged the federal government for insulin pens.

“Not just some, but all of Walgreens’ thousands of pharmacies across the U.S. submitted false insulin pen reimbursement claims and not just for a short duration, but for nearly a decade,” the complaint says. “If the board had a reasonable information and reporting system, it would have known.”

A Walgreens spokesperson told Bloomberg Law on Thursday ...